5-Amino-1MQ
NNMT Inhibitor
Research summary · not a validated human regimen
Open dosage chart
BROWSE THE RESEARCH LIBRARY
Single peptide protocols.
Find a compound and read its research context before interpreting any chart. Strength, formulation and evidence quality matter more than a number alone.
55 research references
A–Z · images shown only for exact matching Peak vials50 mg
Adamax
Adamax (N-Acetyl Semax Amidate)
Research summary · not a validated human regimen
Open dosage chart
Adipotide
FTPP (Fat-Targeted Proapoptotic Peptide)
Research summary · not a validated human regimen
Open dosage chart
AICAR
5-Aminoimidazole-4-carboxamide Ribonucleotide
Research summary · not a validated human regimen
Open dosage chart
View on Peak SINGLEDosage chartAOD-9604
Anti-Obesity Drug 9604
Cited example and evidence context
10 mg research vial · no validated preparation or dosing for supplier products
Open dosage chart
View on Peak SINGLEDosage chartARA-290
Cibinetide / EPO-derived 11-residue peptide
Cited example and evidence context
Research summary · not a validated human regimen
Open dosage chart
View on Peak SINGLEDosage chartBPC-157
Body Protection Compound-157
Research summary · not a validated human regimen
Open dosage chart
View on Peak SINGLEDosage chartCagrilintide
Cagrilintide (Long-Acting Amylin Analogue)
Investigational · published phase 2 dose-finding study
Open dosage chart
Cartalax
Cartalax (Ala-Glu-Asp)
Research summary · not a validated human regimen
Open dosage chart
CJC-1295 DAC
Modified GRF 1-29 (DAC)
Research summary · not a validated human regimen
Open dosage chart
View on Peak SINGLEDosage chartCJC-1295 No DAC
Modified GRF 1-29
Cited example and evidence context
Research summary · not a validated human regimen
Open dosage chart
View on Peak SINGLEDosage chartDSIP
Delta Sleep-Inducing Peptide
Cited example and evidence context
Research summary · not a validated human regimen
Open dosage chart
View on Peak SINGLEDosage chartEpithalon
Epithalamin Synthetic Analog
Research summary · not a validated human regimen
Open dosage chart
FOXO4-DRI
FOXO4-D-Retro-Inverso Peptide
Research summary · not a validated human regimen
Open dosage chart
View on Peak SINGLEDosage chartGHK-Cu
Copper Tripeptide-1
Research summary · not a validated human regimen
Open dosage chart
GHRP-2
Growth Hormone Releasing Peptide-2
Research summary · not a validated human regimen
Open dosage chart
View on Peak SINGLEDosage chartGHRP-6
Growth Hormone Releasing Peptide-6
Cited example and evidence context
Research summary · not a validated human regimen
Open dosage chart
Glutathione
L-Glutathione (Reduced Form / GSH)
Research summary · not a validated human regimen
Open dosage chart
Gonadorelin
Gonadotropin-Releasing Hormone (GnRH)
Research summary · not a validated human regimen
Open dosage chart
View on Peak SINGLEDosage chartHCG
Human Chorionic Gonadotropin
Research summary · not a validated human regimen
Open dosage chart
View on Peak SINGLEDosage chartHGH 191AA
Human Growth Hormone (191 Amino Acid)
Also 32 IU/vial · 320 IU kit · currently out of stock
IU-labelled research kits · 12 or 32 IU per vial; no validated human kit regimen
Open dosage chart
View on Peak SINGLEDosage chartIGF-1 LR3
Long R3 insulin-like growth factor I (experimental analogue)
Experimental analogue · cell and animal evidence; no verified human regimen
Open dosage chart
View on Peak SINGLEDosage chartIpamorelin
Selective GH Secretagogue
Research summary · not a validated human regimen
Open dosage chart
Kisspeptin
Kisspeptin-10 (Metastin)
Research summary · not a validated human regimen
Open dosage chart
View on Peak SINGLEDosage chartKPV
Lysine-Proline-Valine (Alpha-MSH Fragment)
Research summary · not a validated human regimen
Open dosage chart
L-Carnitine
L-Carnitine (Injectable)
Research summary · not a validated human regimen
Open dosage chart
Livagen
Livagen (Lys-Glu-Asp-Ala)
Research summary · not a validated human regimen
Open dosage chart
LL-37
Cathelicidin Antimicrobial Peptide
Research summary · not a validated human regimen
Open dosage chart
Mazdutide
Mazdutide (LY3305677 / IBI362)
Research summary · not a validated human regimen
Open dosage chart
View on Peak SINGLEDosage chartMelanotan II
MT-II · synthetic alpha-MSH analogue
Research summary · not a validated human regimen
Open dosage chart
MGF
Mechano Growth Factor
Research summary · not a validated human regimen
Open dosage chart
MK-677
Ibutamoren Mesylate
Research summary · not a validated human regimen
Open dosage chart
View on Peak SINGLEDosage chartMOTS-C
Mitochondrial-derived peptide MOTS-c
Also available: 20 mg vial
Cited example and evidence context
Preclinical research · no validated human research-vial regimen
Open dosage chart
View on Peak SINGLEDosage chartNAD+
Nicotinamide Adenine Dinucleotide
Cited example and evidence context
Research summary · not a validated human regimen
Open dosage chart
View on Peak SINGLEDosage chartOxytocin
Oxytocin (The Bonding Peptide)
Research summary · not a validated human regimen
Open dosage chart
View on Peak SINGLEDosage chartPE-22-28
Spadin-Derived TREK-1 Research Peptide
Cited example and evidence context
Research summary · not a validated human regimen
Open dosage chart
PEG-MGF
PEGylated Mechano Growth Factor
Research summary · not a validated human regimen
Open dosage chart
Pinealon
Pinealon (Glu-Asp-Arg)
Research summary · not a validated human regimen
Open dosage chart
View on Peak SINGLEDosage chartPNC-27
p53-derived chimeric research peptide
Cited example and evidence context
Preclinical research · no validated human research-vial regimen
Open dosage chart
View on Peak SINGLEDosage chartPT-141
Bremelanotide
Research summary · not a validated human regimen
Open dosage chart
View on Peak SINGLEDosage chartRetatrutide
Triple Agonist (GLP-1/GIP/Glucagon)
Also available: 20 mg vial
Investigational · published human trial
Open dosage chart
View on Peak SINGLEDosage chartSelank
Tuftsin Analog
Research summary · not a validated human regimen
Open dosage chart
Semaglutide
GLP-1 Receptor Agonist
Approved medicine · formulation-specific label
Open dosage chart
View on Peak SINGLEDosage chartSemax
Heptapeptide Analog of ACTH
Research summary · not a validated human regimen
Open dosage chart
View on Peak SINGLEDosage chartSermorelin
Sermorelin Acetate (GHRH 1-29)
Research summary · not a validated human regimen
Open dosage chart
View on Peak SINGLESLU-PP-332
Experimental ERR agonist (small molecule, not a peptide)
Cited example and evidence context
Preclinical small molecule · no established human administration route
Explore protocol
View on Peak SINGLEDosage chartSS-31
SS-31 (Elamipretide / Bendavia)
Research summary · not a validated human regimen
Open dosage chart
Survodutide
Survodutide (BI 456906)
Research summary · not a validated human regimen
Open dosage chart
View on Peak SINGLEDosage chartTB-500
Thymosin Beta-4 Fragment
Research summary · not a validated human regimen
Open dosage chart
View on Peak SINGLEDosage chartTesamorelin
GHRH Analog
Cited example and evidence context
Research summary · not a validated human regimen
Open dosage chart
Testagen
Testagen (Lys-Glu-Asp-Gly)
Research summary · not a validated human regimen
Open dosage chart
View on Peak SINGLEDosage chartThymosin Alpha-1
Thymosin Alpha-1 (Tα1)
Research summary · not a validated human regimen
Open dosage chart
View on Peak SINGLEDosage chartTirzepatide
Dual Agonist (GLP-1/GIP)
Approved medicine · label context differs from research vials
Open dosage chart
Vesugen
Vesugen (Lys-Glu-Asp)
Research summary · not a validated human regimen
Open dosage chart
Vilon
Vilon (Lys-Glu)
Research summary · not a validated human regimen
Open dosage chart
The presence of a research entry is not a human-use recommendation. Supplier products marked for in-vitro research must not be treated as interchangeable with approved medicines.